Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin

Human Molecular Genetics

Volumn 12, Issue 21, 2003, Pages 2765-2776

  Saunders, Aleister J ^a,h   Bertram, Lars ^a   Mullin, Kristina ^a   Sampson, Andrew J ^a   Latifzai, Khushal ^a   Basu, Sanjay ^a   Jones, Jennifer ^a   Kinney, Devon ^a   MacKenzie Ingano, Laura ^a   Yu, Stephen ^a   Albert, Marilyn S ^a,b   Moscarillo, Thomas J ^a   Go, Rodney C P ^c   Bassett, Susan S ^d   Daly, Mark J ^e   Laird, Nan M ^f   Wang, Xin ^g   Velicelebi, Gonul ^g   Wagner, Steven L ^g   Becker, David K ^g   Tanzi, Rudolph E ^a   Blacker, Deborah ^a,f   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g Neurogenetics Inc   (United States)

^h DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CHROMOSOME 12; CONTROLLED STUDY; FAMILY; FAMILY HISTORY; FEMALE; GENE DELETION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS;

AGED; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; CHROMOSOMES, HUMAN, PAIR 12; FEMALE; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC;

EID: 10744226703     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg310     Document Type: Article

References (80)

1. Daw, E.W., Payami, H., Nemens, E.J., Nochlin, D., Bird, T.D., Schellenberg, G.D. and Wijsman, E.M. (2000) The number of trait loci in late-onset Alzheimer disease. Am. J. Hum. Genet., 66, 196-204.
2. Mayeux, R., Lee, J.H., Romas, S.N., Mayo, D., Santana, V., Williamson, J., Ciappa, A., Rondon, H.Z., Estevez, P., Lantigua, R. et al. (2002) Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics. Am. J. Hum. Genet., 70, 237-243.
3. Myers, A., Wavrant De-Vrieze, F., Holmans, P., Hamshere, M., Crook, R., Compton, D., Marshall, H., Meyer, D., Shears, S., Booth, J. et al. (2002) Full genome screen for Alzheimer disease: Stage II analysis. Am. J. Hum. Genet., 114, 235-244.
4. Pericak-Vance, M.A., Bass, M.P., Yamaoka, L.H., Gaskell, P.C., Scott, W.K., Terwedow, H.A., Menold, M.M., Conneally, P.M., Small, G.W., Vance, J.M. et al. (1997) Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA, 278, 1237-1241.
5. Poduslo, S.E. and Yin, X. (2001) Chromosome 12 and late-onset Alzheimer's disease. Neurosci. Lett., 310, 188-190.
6. Rogaeva, E., Premkumar, S., Song, Y., Sorbi, S., Brindle, N., Paterson, A., Duara, R., Levesque, G., Yu, G., Nishimura, M. et al. (1998) Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA, 280, 614-618.
7. Scott, W.K., Grubber, J.M., Abou-Donia, S.M., Church, T.D., Saunders, A.M., Roses, A.D., Pericak-Vance, M.A., Conneally, P.M., Small, G.W. and Haines, J.L. (1999) Further evidence linking late-onset Alzheimer disease with chromosome 12. JAMA, 281, 513-514.
8. Scott, W.K., Grubber, J.M., Conneally, P.M., Small, G.W., Hulette, C.M., Rosenberg, C.K., Saunders, A.M., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. (2000) Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. Am. J. Hum. Genet., 66, 922-932.
9. Wu, W.S., Holmans, P., Wavrant-DeVrieze, F., Shears, S., Kehoe, P., Crook, R., Booth, J., Williams, N., Perez-Tur, J., Roehl, K. et al. (1998) Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA, 280, 619-622.
10. Blacker, D., Wilcox, M.A., Laird, N.M., Rodes, L., Horvath, S.M., Go, R.C., Perry, R., Watson, B., Jr., Bassett, S.S., McInnis, M.G. et al. (1998) Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet., 19, 357-360.
11. Borth, W. (1992) Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J., 6, 3345-3353.
12. Barrett, A.J. and Starkey, P.M. (1973) The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochem. J., 133, 709-724.
13. Harpel, P.C. (1973) Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure. J. Exp. Med., 138, 508-521.
14. Sottrup-Jensen, L., Sand, O., Kristensen, L. and Fey, G.H. (1989) The alpha-macroglobulin bait region. Sequence diversity and localization of cleavage sites for proteinases in five mammalian alpha- macroglobulins. J. Biol. Chem., 264, 15781-15789.
15. Lauer, D., Reichenbach, A. and Birkenmeier, G. (2001) Alpha 2-macroglobulin-mediated degradation of amyloid beta 1-42: a mechanism to enhance amyloid beta catabolism. Exp. Neurol., 167, 385-392.
16. Qiu, W.Q., Borth, W., Ye, Z., Haass, C., Teplow, D.B. and Selkoe, D.J. (1996) Degradation of amyloid beta-protein by a serine protease-alpha2-macroglobulin complex. J. Biol. Chem., 271, 8443-8451.
17. Strickland, D.K., Ashcom, J.D., Williams, S., Burgess, W.H., Migliorini, M. and Argraves, W.S. (1990) Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem., 265, 17401-17404.
18. Du, Y., Bales, K.R., Dodel, R.C., Liu, X., Glinn, M.A., Horn, J.W., Little, S.P. and Paul, S.M. (1998) Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J. Neurochem., 70, 1182-1188.
19. Hughes, S.R., Khorkova, O., Goyal, S., Knaeblein, J., Heroux, J., Riedel, N.G. and Sahasrabudhe, S. (1998) Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation. Proc. Natl Acad. Sci. USA, 95, 3275-3280.
20. Narita, M., Holtzman, D.M., Schwartz, A.L. and Bu, G. (1997) Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem., 69, 1904-1911.
21. Carter, D.B., Dunn, E., McKinley, D.D., Stratman, N.C., Boyle, T.P., Kuiper, S.L., Oostveen, J.A., Weaver, R.J., Boller, J.A. and Gurney, M.E. (2001) Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain. Ann. Neurol., 50, 468-475.
22. Krimbou, L., Tremblay, M., Davignon, J. and Cohn, J.S. (1998) Association of apolipoprotein E with alpha2-macroglobulin in human plasma. J. Lipid Res., 39, 2373-2386.
23. Blacker, D., Bertram, L., Saunders, A.J., Moscarillo, T.J., Albert, M., Wiener, H., Perry, R., Collins, J.S., Harrell, L.E., Go, R.C.P. et al. (2003) Results of a high resolution genome screen of 437 Alzheimer's disease families. Hum. Mol. Genet., 12, 23-32.
24. Blacker, D., Crystal, A.S., Wilcox, M.A., Laird, N.M. and Tanzi, R.E. (1999) In reply Nat. Genet., 22, 21-22.
25. Poduslo, S.E., Shook, B., Drigalenko, E. and Yin, X. (2002) Lack of association of the two polymorphisms in alpha-2 macroglobulin with Alzheimer disease. Am. J. Med. Genet., 110, 30-35.
26. Rudrasingham, V., Wavrant-De Vrieze, F., Lambert, J.C., Chakraverty, S., Kehoe, P., Crook, R., Amouyel, P., Wu, W., Rice, F., Perez-Tur, J. et al. (1999) Alpha-2 macroglobulin gene and Alzheimer disease. Nat. Genet., 22, 17-19.
27. Romas, S.N., Mayeux, R., Rabinowitz, D., Tang, M.X., Zadroga, H.R., Lantigua, R., Medrano, M., Tycko, B. and Knowles, J.A. (2000) The deletion polymorphism and Val10001le in alpha-2-macroglobulin and Alzheimer disease in Caribbean Hispanics. Neurosci. Lett., 279, 133-136.
28. Rogaeva, E.A., Premkumar, S., Grubber, J., Serneels, L., Scott, W.K., Kawarai, T., Song, Y., Hill, D.L., Abou-Donia, S.M., Martin, E.R. et al. (1999) An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat. Genet., 22, 19-22.
29. Zappia, M., Cittadella, R., Manna, I., Nicoletti, G., Andreoli, V., Bonavita, S., Gambardella, A. and Quattrone, A. (2002) Genetic association of alpha-2-macroglobulin polymorphisms with AD in southern Italy. Neurology, 59, 756-758.
30. Nacmias, B., Tedde, A., Cellini, E., Forleo, P., Orlacchio, A., Guarnieri, B.M., Petruzzi, C., D'Andrea, F., Serio, A. and Sorbi, S. (2001) Alpha2-macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease. Neurosci. Lett., 299, 9-12.
31. Jhoo, J.H., Kim, K.W., Lee, D.Y., Lee, K.U., Lee, J.H., Kim, S.Y., Youn, J.Y., Youn, J.C. and Woo, J.I. (2001) Association of alpha-2-macroglobulin deletion polymorphism with sporadic Alzheimer's disease in Koreans. J. Neurol. Sci., 184, 21-25.
32. Dodel, R.C., Du, Y., Bales, K.R., Gao, F., Eastwood, B., Glazier, B., Zimmer, R., Cordell, B., Hake, A., Evans, R. et al. (2000) Alpha2 macroglobulin and the risk of Alzheimer's disease. Neurology, 54, 438-442.
33. Alvarez, V., Alvarez, R., Lahoz, C.H., Martinez, C., Pena, J., Guisasola, L.M., Salas-Puig, J., Moris, G., Uria, D., Menes, B.B. et al. (1999) Association between an alpha(2) macroglobulin DNA polymorphism and late- onset Alzheimer's disease. Biochem. Biophys. Res. Commun., 264, 48-50.
34. Liao, A., Nitsch, R.M., Greenberg, S.M., Finckh, U., Blacker, D., Albert, M., Rebeck, G.W., Gomez-Isla, T., Clatworthy, A., Binetti, G. et al. (1998) Genetic association of an alpha2-macroglobulin (Val10001le) polymorphism and Alzheimer's disease. Hum. Mol. Genet., 7, 1953-1956.
35. Myllykangas, L., Polvikoski, T., Sulkava, R., Verkkoniemi, A., Crook, R., Tienari, P.J., Pusa, A.K., Nimisto, L., O'Brien, P., Kontula, K. et al. (1999) Genetic association of alpha2-macroglobulin with Alzheimer's disease in a Finnish elderly population. Ann. Neurol., 46, 382-390.
36. Tang, G., Zhang, M., Xie, H., Jiang, S., Wang, Z., Xu, L., Hao, Y., Lin, D., Lan, H., Wang, Y. et al. (2002) Aplha-2 macroglobulin I1000 V polymorphism in Chinese sporadic Alzheimer's disease and Parkinson's disease. Neurosci. Lett., 328, 195-197.
37. Wang, X., Luedecking, E.K., Minster, R.L., Ganguli, M., DeKosky, S.T. and Kamboh, M.I. (2001) Lack of association between alpha2-macroglobulin polymorphisms and Alzheimer's disease. Hum. Genet., 108, 105-108.
38. Wavrant-DeVrieze, F., Rudrasingham, V., Lambert, J.C., Chakraverty, S., Kehoe, P., Crook, R., Amouyel, P., Wu, W., Holmans, P., Rice, F. et al. (1999) No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease. Neurosci. Lett., 262, 137-139.
39. Verpillat, P., Bouley, S., Hannequin, D., Belliard, S., Puel, M., Thomas-Anterion, C., Dubois, B., Agid, Y., Campion, D., Clerget-Darpoux, F. et al. (2000) Alpha2-macroglobulin gene and Alzheimer's disease: confirmation of association by haplotypes analyses. Ann. Neurol., 48, 400-402.
40. Blacker, D., Haines, J.L., Rodes, L., Terwedow, H., Go, R.C., Harrell, L.E., Perry, R.T., Bassett, S.S., Chase, G., Meyers, D. et al. (1997) ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology, 48, 139-147.
41. Risch, N.J. (2000) Searching for genetic determinants in the new millennium. Nature, 405, 847-856.
42. Spielman, R.S., McGinnis, R.E. and Ewens, W.J. (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet., 52, 506-516.
43. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939-944.
44. Blacker, D., Albert, M.S., Bassett, S.S., Go, R.C., Harrell, L.E. and Folstein, M.F. (1994) Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. Arch. Neurol., 51, 1198-1204.
45. Chen, X., Levine, L. and Kwok, P.Y. (1999) Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res., 9, 492-498.
46. Rabinowitz, D. and Laird, N. (2000) A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum. Hered., 50, 211-223.
47. Laird, N.M., Horvath, S. and Xu, X. (2000) Implementing a unified approach to family-based tests of association. Genet. Epidemiol., 19, S36-42.
48. Tu, I.P., Balise, R.R. and Whittemore, A.S. (2000) Detection of disease genes by use of family data. II. Application to nuclear families. Am. J. Hum. Genet., 66, 1341-1350.
49. Lake, S.L., Blacker, D. and Laird, N.M. (2000) Family-based tests of association in the presence of linkage. Am. J. Hum. Genet., 67, 1515-1525.
50. Whittaker, J.C. and Lewis, C.M. (1998) The effect of family structure on linkage tests using allelic association: Am. J. Hum. Genet., 63, 889-897.
51. Lunetta, K.L., Faraone, S.V., Biederman, J. and Laird, N.M. (2000) Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions. Am. J. Hum. Genet., 66, 605-614.
52. Lange, C. and Laird, N.M. (2002) On a general class of conditional tests for family-based association studies in genetics: the asymptotic distribution, the conditional power, and optimality considerations. Genet. Epidemiol., 23, 165-180.
53. Witte, J.S., Gauderman, W.J. and Thomas, D.C. (1999) Asymptotic bias and efficiency in case-control studies of candidate genes and gene-environment interactions: basic family designs. Am. J. Epidemiol., 149, 693-705.
54. Siegmund, K.D., Langholz, B., Kraft, P. and Thomas, D.C. (2000) Testing linkage disequilibrium in sibships. Am. J. Hum. Genet., 67, 244-248.
55. Clayton, D. (1999) A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am. J. Hum. Genet., 65, 1170-1177.
56. Akey, J., Jin, L. and Xiong, M. (2001) Haplotypes vs single marker linkage disequilibrium tests: what do we gain? Eur. J. Hum. Genet., 9, 291-300.
57. Horvath, S., Xu, X., Lake, S.L., Silverman, E.K., Weiss, S.T. and Laird, N.M. (2003) Family based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet. Epidemiol., in press.
58. Bagli, M., Papassotiropoulos, A., Jessen, F., Schmitz, S., Rao, M.L., Maier, W. and Heun, R. (2000) Identical distribution of the alpha 2-macroglobulin pentanucleotide deletion in subjects with Alzheimer disease and controls in a German population. Am. J. Med. Genet., 96, 775-777.
59. Blennow, K., Ricksten, A., Prince, J.A., Brookes, A.J., Emahazion, T., Wasslavik, C., Bogdanovic, N., Andreasen, N., Batsman, S., Marcusson, J. et al. (2000) No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression. J. Neural. Transm., 107, 1065-1079.
60. Bullido, M.J., Guallar-Castillon, P., Artiga, M.J., Ramos, M.C., Sastre, I., Aldudo, J., Frank, A., Coria, F., Rodriguez-Artalejo, F. and Valdivieso, F. (2000) Alzheimer's risk associated with human apolipoprotein E, alpha-2 macroglobulin and lipoprotein receptor related protein polymorphisms: absence of genetic interactions, and modulation by gender. Neurosci. Lett., 289, 213-216.
61. Chen, L., Baum, L., Ng, H.K., Chan, L.Y., Sastre, I., Artiga, M.J., Valdivieso, F., Bullido, M.J., Chiu, H.F. and Pang, C.P. (1999) Apolipoprotein E promoter and alpha2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease. Neurosci. Lett., 269, 173-177.
62. Crawford, F., Town, T., Freeman, M., Schinka, J., Gold, M., Duara, R. and Mullan, M. (1999) The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sample. Neurosci. Lett., 270, 133-136.
63. Dow, D.J., Lindsey, N., Cairns, N.J., Brayne, C., Robinson, D., Huppert, F.A., Paykel, E.S., Xuereb, J., Wilcock, G., Whittaker, J.L. et al. (1999) Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat. Genet., 22, 16-17; discussion 21-12.
64. Gibson, A.M., Singleton, A.B., Smith, G., Woodward, R., McKeith, I.G., Perry, R.H., Ince, P.G., Ballard, C.G., Edwardson, J.A. and Morris, C.M. (2000) Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD. Neurology, 54, 433-438.
65. Halimi, G., Duplan, L., Bideau, C., Iniesta, D., Berthezene, P., Oddoze, C., Verdier, J.M., Michel, B. and Berge-Lefranc, J.L. (2000) Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease. Neuroreport, 11, 3599-3601.
66. Higuchi, S., Matsushita, S., Nakane, J., Arai, H., Matsui, T., Urakami, K., Yuzuriha, T. and Takeda, A. (2000) Alpha2-macroglobulin gene polymorphisms show racial diversity and are not associated with Alzheimer's disease. Neuroreport, 11, 1167-1171.
67. Hu, C.J., Sung, S.M., Liu, H.C., Hsu, W.C., Lee, L.S., Lee, C.C., Tsai, C.H. and Chang, J.G. (2000) Genetic risk factors of sporadic Alzheimer's disease among Chinese in Taiwan. J. Neurol. Sci., 181, 127-131.
68. Hu, C.J., Sung, S.M., Liu, H.C., Lee, K.Y., Hsu, W.C., Wong, W.K., Lee, C.C., Tsai, C.H. and Chang, J.G. (1999) No association of alpha-2 macroglobulin gene five-nucleotide deletion with AD in Taiwan Chinese. Neurology, 53, 642-643.
69. Ki, C.S., Na, D.L., Kim, H.J. and Kim, J.W. (2001) Alpha-1 anti-chymotrypsin and alpha-2 macroglobulin gene polymorphisms are not associated with Korean late-onset Alzheimer's disease. Neurosci. Lett., 302, 69-72.
70. Korovaitseva, G.I., Premkumar, S., Grigorenko, A., Molyaka, Y., Galimbet, V., Selezneva, N., Gavrilova, S.I., Farrer, L.A. and Rogaev, E.I. (1999) Alpha-2 macroglobulin gene in early- and late-onset Alzheimer disease. Neurosci. Lett., 271, 129-131.
71. Koster, M.N., Dermaut, B., Cruts, M., Houwing-Duistermaat, J.J., Roks, G., Tol, J., Ott, A., Holman, A., Munteanu, G., Breteler, M.M. et al. (2000) The alpha2-macroglobulin gene in AD: a population-based study and meta-analysis. Neurology, 55, 678-684.
72. Kovacs, T., Cairns, N.J. and Lantos, P.L. (1999) Alpha-2-macroglobulin intronic polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease. Neurosci. Lett., 273, 61-83.
73. McIlroy, S.P., Dynan, K.B., Vahidassr, D.J., Lawson, J.T., Patterson, C.C. and Passmore, P. (2001) Common polymorphisms in LRP and A2M do not affect genetic risk for Alzheimer disease in Northern Ireland. Am. J. Med. Genet., 105, 502-506.
74. Perry, R.T., Collins, J.S., Harrell, L.E., Acton, R.T. and Go, R.C. (2001) Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am. J. Med. Genet., 105, 332-342.
75. Shibata, N., Ohnuma, T., Takahashi, T., Ohtsuka, E., Ueki, A. and Arai, H. (1999) Genetic association between alpha-2 macroglobulin and Japanese sporadic Alzheimer's disease. Neurosci. Lett., 271, 132-134.
76. Singleton, A.B., Gibson, A.M., McKeith, I.G., Ballard, C.A., Perry, R.H., Ince, P.G., Edwardson, J.A. and Morris, C.M. (1999) Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies. Neuroreport, 10, 1507-1510.
77. Sodeyama, N., Yamada, M., Itoh, Y., Suematsu, N., Matsushita, M., Otomo, E. and Mizusawa, H. (2000) Alpha2-macroglobulin polymorphism is not associated with AD or AD-type neuropathology in the Japanese. Neurology, 54, 443-446.
78. Zill, P., Burger, K., Behrens, S., Hampel, H., Padberg, F., Boetsch, T., Moller, H.J., Ackenheil, M. and Bondy, B. (2000) Polymorphisms in the alpha-2 macroglobulin gene in psychogeriatric patients. Neurosci. Lett., 294, 69-72.
79. Shibata, N., Ohnuma, T., Takahashi, T., Ohtsuka, E., Ueki, A., Nagao, M. and Arai, H. (2000) No genetic association between alpha-2 macroglobulin I1000V polymorphism and Japanese sporadic Alzheimer's disease. Neurosci. Lett., 290, 154-156.
80. Styczynska, M., Religa, D., Pfeffer, A., Luczywek, E., Wasiak, B., Styczynski, G., Peplonska, B., Gabryelewicz, T., Golebiowski, M., Kobrys, M. et al. (2003) Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease. Neurosci. Lett., 344, 99-102.